FDA approves tropinetide for treatment of Rett syndrome

Published Date: 16 Mar 2023

The FDA has approved tropinetide (Daybue; Acadia Pharmaceuticals) to treat Rett syndrome in patients 2 years of age and older.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Pickleball program boosts health and wellness for cancer survivors, study finds

2.

Base-edited T-cell therapy offers additional hope for treating resistant leukemia.

3.

Study recommends new grading system for invasive squamous cell carcinoma of the lung

4.

Is Chemotherapy via Peripheral IV Access More Effective Than Central Lines for Testicular Cancer?

5.

In inflammatory breast cancer, ER beta regulates estrogen signaling.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot